pirfenidone has been researched along with ST Elevated Myocardial Infarction in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aimo, A; Bayes-Genis, A; Egea, OI; Emdin, M | 1 |
1 other study(ies) available for pirfenidone and ST Elevated Myocardial Infarction
| Article | Year |
|---|---|
Overlapping Effects of miR-21 Inhibition and Drugs for Idiopathic Pulmonary Fibrosis: Rationale for Repurposing Nintedanib as a Novel Treatment for Ischemia/Reperfusion Injury.
Topics: Animals; Drug Repositioning; Humans; Idiopathic Pulmonary Fibrosis; Indoles; Lung; MicroRNAs; Myocardial Reperfusion Injury; Protein Kinase Inhibitors; Pyridones; Signal Transduction; src-Family Kinases; ST Elevation Myocardial Infarction | 2021 |